Camber Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-725,000
| Closed | -$21.9M | – | 28 |
|
|
2025
Q1 | $21.9M | Buy |
725,000
+100,000
| +16% | +$3.02M | 0.78% | 17 |
|
|
2024
Q4 | $21.9M | Buy |
+625,000
| New | +$21.9M | 0.51% | 26 |
|
|
2024
Q1 | – | Sell |
-865,000
| Closed | -$43.8M | – | 37 |
|
|
2023
Q4 | $43.8M | Sell |
865,000
-1,385,000
| -62% | -$70.1M | 1.12% | 18 |
|
|
2023
Q3 | $102M | Sell |
2,250,000
-250,000
| -10% | -$11.3M | 3.36% | 12 |
|
|
2023
Q2 | $103M | Buy |
2,500,000
+575,000
| +30% | +$23.6M | 3.34% | 11 |
|
|
2023
Q1 | $68.8M | Hold |
1,925,000
| – | – | 2.12% | 15 |
|
|
2022
Q4 | $72.7M | Hold |
1,925,000
| – | – | 2.49% | 14 |
|
|
2022
Q3 | $85.1M | Sell |
1,925,000
-775,000
| -29% | -$34.3M | 2.61% | 14 |
|
|
2022
Q2 | $100M | Sell |
2,700,000
-300,000
| -10% | -$11.1M | 4.34% | 8 |
|
|
2022
Q1 | $111M | Buy |
3,000,000
+1,610,000
| +116% | +$59.6M | 4.02% | 9 |
|
|
2021
Q4 | $42.3M | Sell |
1,390,000
-1,110,000
| -44% | -$33.8M | 1.45% | 21 |
|
|
2021
Q3 | $83.9M | Buy |
2,500,000
+500,000
| +25% | +$16.8M | 2.58% | 15 |
|
|
2021
Q2 | $79.8M | Buy |
2,000,000
+1,000,000
| +100% | +$39.9M | 2.69% | 15 |
|
|
2021
Q1 | $45M | Buy |
+1,000,000
| New | +$45M | 1.54% | 20 |
|